We are live on
!
Find out more
Vanda Pharmaceuticals
VNDA
VNDA
170 hedge funds and large institutions have $319M invested in Vanda Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 63 increasing their positions, 38 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
448% more call options, than puts
Call options by funds: $5.8M | Put options by funds: $1.06M
75% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 28
66% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 38
11% more funds holding
Funds holding: 153 → 170 (+17)
7.3% more ownership
Funds ownership: 70.89% → 78.19% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $369M → $319M (-$50M)
Holders
170
Holders Change
+17
Holders Change %
+11.11%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
49
Increased
63
Reduced
38
Closed
28
Calls
$5.8M
Puts
$1.06M
Net Calls
+$4.74M
Net Calls Change
-$4.74M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$13.5M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$7.53M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$5.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.88M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.6M |
